CABI International

Overview

Results from the recently published paper ‘Accessing public health information: a preliminary comparison of CABI’s Global Health database and Medline’ (Health Information and Libraries Journal, Wiley, Aug 2008) demonstrate the importance of Global Health to public health research:

"Global Health database holds a high proportion of unique records in comparison to Medline."

“The content of Medline is dominated by US (North American 57%) and European publications. Global Health has a more universal outlook, and it indexes more developing country periodicals than Medline.”
 

About Global Health

Global Health is the only specialist bibliographic, abstracting and indexing database dedicated to public health research and practice.

Derived from over 3500 journals, plus reports, books and conferences, Global Health contains over 1.2 million scientific records from 1973 to the present. Over 90,000 records are added each year, and over 95% of these records include an abstract.

Publications from over 158 countries in 50 languages are abstracted, and all relevant non-English-language papers are translated to give access to research not available through any other database.

The database's open serials policy and coverage of international and grey literature means that 40% of material contained in Global Health is unique to the database. Everything from proceedings, patents, theses, electronic only publications and other difficult-to-obtain sources are included.

Why choose Global Health?

-Global Health provides international coverage of all aspects of public health.

-Global Health provides access to ALL relevant research, wherever, and in whatever format, it is published.
 

The people behind the product

The database is produced by CABI subject specialists and an international editorial board advises on its development.
The editorial board is made up of the following:

Delivery Platforms

• Medical microbiology:
  Drug resistance/susceptibility and virulence studies in clinical isolates. Biology of fungal pathogens, parasites and associated vectors.
   
• Physiology:
  Biochemistry and physiology of nutrients and food components in humans, animal models and at a cellular level. Includes bioavailability, nutrient absorption and uptake. Physiology of taste and appetite. Physiological effects of nutrient deficiencies and starvation.
   
• Pharmacology:
  Pharmacological effects of medicinal plant products, antimicrobials and antiparasitic drugs. Nutrient-drug interactions. Clinical trials and safety and efficacy studies. Antiparasitic and antifungal drug development.

•  Bioterrorism:
  In vitro, animal and human studies of potential bioterrorism agents such as those causing anthrax, smallpox, plague, tularaemia, viral haemorrhagic fevers, hantavirus pulmonary syndrome, cholera, dengue, botulinum toxin and other toxins. Public health response, emergency preparedness and studies of incidents.
   
• Disasters: Natural and man-made, e.g. floods, droughts, conflict and wars, injuries, famine or epidemics related to these. Aspects include food aid, sanitation, water quality, emergency medical response, disease outbreak control. The impact on health of a disaster, disaster management and preparedness. 

• Epidemiology:
  Aetiology, incidence and disease- or sero-prevalence of diseases in the general population or larger population groups, such as women or the elderly. Causes, incidence and prevalence of diseases. Molecular epidemiology and studies of risk factors for disease including genetic risk factors. Outbreak investigations.
   
• Biostatistics:
  Statistics applied to infectious diseases, epidemiological and nutritional research including modelling and methods. Health data such as mortality and morbidity rates. Population and demographic statistics. Life expectancy and disability adjusted life years (DALYS).

• Clinical infectious and parasitic diseases:
  Clinical diagnosis of infectious and parasitic diseases; screening for chronic diseases and latent infection including development of new methods.Treatment of infectious and parasitic diseases including clinical trials of safety and efficacy of drugs, use of drug combinations. Clinical aspects of infectious diseases. The body’s response to infection and immunization. Adverse and side effects of treatment.
   
• Nutritional therapy and phytotherapy:
  Use of medicinal plants and nutrients in treatment of disease. Clinical nutrition: parenteral and enteral feeding, therapeutic diets, nutritional assessment and nutritional support. Food supplements.

Health systems

• Health economics:
  Economic impact of illness/specific diseases at individual/national level, economics of safety/hygiene at work, food safety, economics of public health and disease prevention/control, health service costs, socioeconomics, health insurance, traditional medicine costs, rural health economics, economic impact of crises/epidemics, development aid, emergency aid.
   
• Health policy and planning:
  All public health policy, planning and decision-making for health services at the regional, national and international level.
   
• Health services:
  Low-income and transitional economy health services: research, management, access to care, monitoring, delivery, organization, efficiency, use and cost. Health services in rural areas and for infectious diseases.
   
• Chronic diseases:
   Epidemiology of cancer, heart disease, allergy and other chronic diseases in the general population. Studies of risk factors for chronic diseases including genetic factors and risk behaviours such as smoking. Diet influences on chronic diseases. Prevention of chronic disease e.g.
  by diet and lifestyle or behavioural changes. Management of chronic disease in resource poor settings
   
• Traditional medicine including medicinal plants:
   Traditional Chinese medicine and Ayurvedic medicines involving herbal components. Phytomedicines and phytotherapy. Pharmacological studies.
   
• Evidence-based medicine
   Systematic reviews, meta-analyses, randomized controlled trials, case-controlled trials and cohort studies in epidemiology, diagnosis
  and clinical trials.

Updates to this list are produced every three months. Further improvements to the list are planned, including designation of Open Access publications.

How to submit a title for inclusion >>

Download as text file >>

Show only newly added titles (last three months)

Search for a specific term:      

ALLABCDEFGHIJKLMNOPQRSTUVWXYZ